|
Targeting the Super Elongation Complex to Prevent Hematopoietic Stem Cell Expansion and Blood Cancer Risk
Targeting the Super Elongation Complex to Prevent Hematopoietic Stem Cell Expansion and Blood Cancer Risk
Background
It is estimated that over 1.7 million people in the United States are living with or in remission from blood cancers such as leukemias, lymphomas, myeloma, and myeloproliferative neoplasms (MPNs), and approximately 192,070 new cases...
Published: 3/26/2026
|
Updated: 12/19/2025
|
Inventor(s): Vijay Sankaran, Jiawei Zhao, Liam Cato
Keywords(s): Blood Cancer
Category(s): Technology Classifications > Disease Area > Hematology/Oncology, Technology Classifications > Invention Type > Novel Targets
|
